Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation

Novartis Foundation Symposium

Volumn 274, Issue , 2006, Pages 3-12

  Olson, Eric N ^b   Backs, Johannes ^a   McKinsey, Timothy A ^a  

^a Myogen Inc   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE DEACETYLASE;

ACETYLATION; ANIMAL; AUDIOVISUAL EQUIPMENT; BIOLOGICAL MODEL; CARDIOMEGALY; CONGESTIVE HEART FAILURE; GENETIC TRANSCRIPTION; HEART DISEASE; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVIEW;

ACETYLATION; ANIMALS; CARDIOMEGALY; HEART DISEASES; HEART FAILURE, CONGESTIVE; HISTONE DEACETYLASES; HISTONES; HUMANS; MODELS, ANATOMIC; MODELS, BIOLOGICAL; PHOSPHORYLATION; TRANSCRIPTION, GENETIC;

EID: 36148962539     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (29)

1. Abraham WT, Gilbert EM, Lowes BD et al 2002 Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med 8:750-760
2. Antos CL, McKinsey TA, Dreitz M et al 2003 Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278:28930-28937
3. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ 2003 Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41:1096-1106
4. Braunwald E, Bristow MR 2000 Congestive heart failure: fifty years of progress. Circulation 102:IV14-23
5. Bush E, Fielitz J, Melvin L et al 2004 A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci USA 101:2870-2875
6. Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA, Olson EN 2004 Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24:8467-8476
7. Chen SL, Loffler KA, Chen D, Stallcup MR, Muscat GE 2002 The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. J Biol Chem 277:4324-4333
8. Chien KR 1999 Stress pathways and heart failure. Cell 98:555-558
9. Fischle W, Wang Y, Allis CD 2003 Histone and chromatin cross-talk. Curr Opin Cell Biol 15:172-183
10. Frey N, Olson EN 2003 Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79
11. Grozinger CM, Schreiber SL 2000 Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 97:7835-7840
12. Hassig CA, Tong JK, Schreiber SL 1997 Fiber-derived butyrate and the prevention of colon cancer. Chem Biol 4:783-789
13. Herron TJ, McDonald KS 2002 Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 90:1150-1152
14. Kook H, Lepore JJ, Gitler AD et al 2003 Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112:863-871
15. Lowes BD, Gilbert EM, Abraham WT et al 2002 Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346:1357-1365
16. McKinsey TA, Olson EN 2004 Cardiac histone acetylation - therapeutic opportunities abound. Trends Genet 20:206-213
17. McKinsey TA, Zhang CL, Lu J, Olson EN 2000a Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-111
18. McKinsey TA, Zhang CL, Olson EN 2000b Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci USA 97:14400-14405
19. McKinsey TA, Zhang CL, Olson EN 2001 Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol 21:6312-6321
20. McKinsey TA, Zhang CL, Olson EN 2002 MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27:40-47
21. Molkentin JD, Dorn II GW 2nd 2001 Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426
22. Nozato T, Ito H, Tamamori M et al 2000 G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J 64:595-601
23. Olson EN, Schneider MD 2003 Sizing up the heart: development redux in disease. Genes Dev 17:1937-1956
24. Vega RB, Harrison BC, Meadows E et al 2004 Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24:8374-8385
25. Verdin E, Dequiedt F, Kasler HG 2003 Class II histone deacetylases: versatile regulators. Trends Genet 19:286-293
26. Wang AH, Yang XJ 2001 Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol Cell Biol 21:5992-6005
27. Yanazume T, Hasegawa K, Morimoto T et al 2003 Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 23:3593-3606
28. Youn HD, Grozinger CM, Liu JO 2000 Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J Biol Chem 275:22563-22567
29. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN 2002 Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479-488